Evidence map›Paper›PMID 40845049›Full record

ArticlePLoS neglected tropical diseases2025

Epidemiological, temporal, and geographic trends of leptospirosis in the United States, 2014-2020.

Christine Atherstone, Renee Galloway, Ilana Schafer, Aileen Artus, Melissa Marzan Rodriguez, Kyle Ryff, Abigail Medina Rivera, Sally Slavinski, Marc Paladini, Sarah K Kemble and 10 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Phylogenetic evidence of possible zoonotic circulation ofOne health (Amsterdam, Netherlands) · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Christine AtherstoneBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.ORCID 0000-0003-1665-8002
Renee GallowayBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Ilana SchaferBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Aileen ArtusBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Melissa Marzan RodriguezPuerto Rico Department of Health, San Juan, Puerto Rico, United States of America.
Kyle RyffPuerto Rico Department of Health, San Juan, Puerto Rico, United States of America.
Abigail Medina RiveraPuerto Rico Department of Health, San Juan, Puerto Rico, United States of America.
Sally SlavinskiNew York City Department of Health and Mental Hygiene, New York City, New York, United States of America.
Marc PaladiniNew York City Department of Health and Mental Hygiene, New York City, New York, United States of America.
Sarah K KembleHawaii State Department of Health, Honolulu, Hawaii, United States of America.
Janet M BerremanHawaii State Department of Health, Kauai, Hawaii, United States of America.
Grayson KallasHawaii State Department of Health, Kauai, Hawaii, United States of America.
Rita TraxlerBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Grishma KharodBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Marta GuerraBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Robyn A StoddardBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Hannah MooreBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
William A BowerBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Maria E NegronBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.
Katherine DeBordBacterial Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC, Atlanta, Georgia, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeptospirosis, caused by pathogenic Leptospira spp., is one of the most widespread zoonotic diseases globally. In 2014, leptospirosis was reinstated as a nationally notifiable condition due to evidence of increasing incidence and public health importance. We describe the epidemiological, temporal, and geographic trends of leptospirosis in the United States since reinstatement. METHODOLOGY: Analysis included confirmed and probable leptospirosis cases from jurisdictions reporting ≥ 1 case between 2014-2020. Analyzed data included reportable case surveillance and voluntarily submitted supplemental data. PRINCIPAL

findingsBetween 2014-2020, CDC received 1,053 case reports from 34 jurisdictions. The national incidence rate was 0.48 cases per 100,000 population. Since 2014, leptospirosis cases have been increasing, with an average annual gain of 13 cases (R2 = 0.69). Cases increased in summer, peaking in early fall, corresponding with warmer weather and hurricane season. Among cases with outcome data, 85% (n = 606/709) were hospitalized and 10% (n = 74) died. Seventy-seven percent of cases (n = 623) reported contact with animals or their bodily fluids while 71% (n = 578) of cases reported contact with freshwater or mud. More cases reported avocational activities (n = 413, [52%]) as the source of their animal or environmental exposure(s) than recreational or occupational activities (n = 203, [25%] vs n = 163, [20%], respectively). Only 13% of cases reported any international travel in the 30 days prior to symptom onset.

conclusionsAn increasing number of leptospirosis cases in the U.S. are being reported, mostly from domestic sources of infection. Changing epidemiological trends away from occupational exposures to avocational or recreational activities highlights the need for interventions mitigating these exposure risks. A high percentage of cases were hospitalized and died emphasizing the need to educate healthcare providers, public health professionals, and the public about early identification and treatment for leptospirosis to improve patient outcomes.

Indexed as

LeptospirosisAdolescentAdultAgedAnimalsChildChild, PreschoolFemaleHumansIncidenceInfantLeptospiraMaleMiddle AgedSeasonsUnited States

Identifiers

PMID40845049
PMCPMC12413079

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.